ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,927Medicare Part D Prescriptions Filled, Including Refills

Rank: 60 out of 890

$848K Total Retail Price of All Prescriptions

Rank: 83 out of 890

569 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
48% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 569 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

23% of this provider’s 569 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

4% of this provider’s 12,552 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
HYDROCODONE-ACETAMINOPHEN 1,086 497 S3 1 3
LEVOTHYROXINE SODIUM 611 514 2 2
SIMVASTATIN 578 449 3 5
FUROSEMIDE 476 369 4 7
MELOXICAM 467 366 5 18
HYDROCHLOROTHIAZIDE 466 397 6 9
AMLODIPINE BESYLATE 379 302 7 1
GABAPENTIN 326 186 8 12
ZOLPIDEM TARTRATE 317 209 9 19
NEXIUM 266 149 10 14
METFORMIN HCL 261 219 11 6
OMEPRAZOLE 254 219 12 8
LISINOPRIL 232 141 13 4
CARVEDILOL 223 171 14 22
ALLOPURINOL 220 205 15 31
LOSARTAN-HYDROCHLOROTHIAZIDE 217 205 16 57
TRAMADOL HCL 211 167 17 16
POTASSIUM CHLORIDE 209 182 18 11
PANTOPRAZOLE SODIUM 176 158 19 34
AZITHROMYCIN 169 103 20 37
ATENOLOL 161 136 21 23
CLOPIDOGREL 155 119 22 28
ATORVASTATIN CALCIUM 147 130 23 13
LISINOPRIL-HYDROCHLOROTHIAZIDE 143 136 24 21
CLONIDINE HCL 135 75 25 35
METOPROLOL TARTRATE 124 103 26 15
DONEPEZIL HCL 124 114 26 30
AMITRIPTYLINE HCL 122 75 R 28 43
CARISOPRODOL 122 18 R 28 69
SERTRALINE HCL 120 92 30 26
WARFARIN SODIUM 120 119 30 24
LEVOFLOXACIN 114 97 32 107
GLIMEPIRIDE 111 103 33 27
PROMETHAZINE HCL 110 47 R 34 104
PRAVASTATIN SODIUM 107 99 35 10
LYRICA 107 89 35 71
PREMARIN 107 100 R 35 105
CRESTOR 106 69 38 25
GLIPIZIDE 105 63 39 62
DIOVAN 105 86 39 33
PLAVIX 105 77 39 42
SULFAMETHOXAZOLE-TRIMETHOPRIM 99 71 42 76
ENALAPRIL MALEATE 98 76 43 56
TRIAMTERENE-HCTZ 97 85 44 61
LANTUS 97 74 44 50
DEXILANT 92 69 46 138
CYMBALTA 90 35 47 45
CITALOPRAM HBR 89 71 48 20
TRAZODONE HCL 88 43 49 40
GLYBURIDE 88 70 R 49 83
IBUPROFEN 83 50 51 101
VERAPAMIL ER 81 81 52 87
DIGOXIN 78 58 53 65
FENOFIBRATE 77 56 54 74
CELEBREX 74 53 55 91
LOSARTAN POTASSIUM 73 51 56 29
ESCITALOPRAM OXALATE 73 60 56 51
DIPHENOXYLATE-ATROPINE 71 39 58 358
METOPROLOL SUCCINATE 70 62 59 17
DILTIAZEM ER 69 64 60 129
MECLIZINE HCL 69 56 60 97
NAMENDA 68 68 62 36
SPIRONOLACTONE 68 67 62 85
RAMIPRIL 67 67 64 80
KLOR-CON 8 67 49 64 268
CYCLOBENZAPRINE HCL 67 51 R 64 64
ZETIA 67 51 64 81
EVISTA 61 61 68 182
POLYETHYLENE GLYCOL 3350 61 54 68 67
SYNTHROID 60 57 70 53
FLUOXETINE HCL 60 43 70 63
NIFEDIPINE ER 58 52 72 75
AMLODIPINE BESYLATE-BENAZEPRIL 56 56 73 41
VYTORIN 56 56 73 183
INSULIN SYRINGE 56 41 73 99
ROPINIROLE HCL 54 40 76 93
NAPROXEN 53 32 77 84
DIOVAN HCT 52 44 78 48
BENICAR HCT 51 51 79 166
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 26, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.